Endocrinology

Dechra Limited has purchased Akston Biosciences’ developmental therapies for cats and dogs with diabetes

How new medications on the market are improving the lives of cats and pet owners.

Therapeutic success can be maximized through dietary modifications

Felanorm is the first generic methimazole oral solution is the first generic indicated for the disease in felines, and contains the same active ingredient as Felimazole Coated Tablets.

A new peer-reviewed paper published in BMC Veterinary Research shows the potential veterinary use of weight loss drug implant

Trupanion analyzed over 20 years’ worth of data to identify common concerns for cats

This new questionnaire was tested for validation of effectiveness in determining quality-of-life measures for this endocrine disease

Nationwide reveals the most common reason pets sought out veterinary care in 2023

An overview of this life-threatening condition will help guide veterinary practitioners

The program is expected to discuss a new oral hypoglycaemic agent (SGLT2-inhibitor) for management of feline diabetes

The Akston Biosciences technology is used to design therapies for humans and animals with diabetes

A recent study investigates therapeutic strategies for dogs with the disease that may also benefit humans with diabetes

Dr Whit Cothern explains how velagliflozin oral solution can help pet owners achieve medication adherence with their cats

We have compiled a countdown of our top 15 articles in 2023, here is number 15

Learn more about how velagliflozin oral solution is changing the game for managing diabetes in cats

Check out this week’s headlines

A novel class of drugs normalizes blood glucose in type 2 diabetic cats by dumping sugar into urine rather than modulating glucose uptake in the tissues but patient selection and close monitoring are crucial to using them safely

A discussion on the traditional treatments for feline diabetes, with an introduction to some newer options coming to the market

Fetch Coastal lecturer Liza Wysong, BAS, RVT, VTS (CP-CF, SAIM), describes the discrepancies of this disease in dog and cat patients and the importance of an individualized approach

Fuzapladib sodium for injection can help manage clinical signs associated with the acute onset of pancreatitis, a common disorder in canine patients

The diagnostic tool tests eACTH in plasma from horses and is compatible with Zomedica’s existing in-clinic platform

This program has been approved for 0.5 hour of continuing education credit in jurisdictions that recognize RACE approval.

Akston Biosciences Corporation is working to development drugs to treat diabetes in pets as well as chronic pain in dogs and canine cancers

SENVELGO is a once daily medication to improve glycemic control in cats with diabetes mellitus

Learn and earn 0.25 CE credits online with dvm360 Flex